Neurocognition in Post-Treatment Lyme Disease and Major Depressive Disorder
Author(s) -
John G. Keilp,
Kathy Corbera,
Marianne Gorlyn,
María A. Oquendo,
J. John Mann,
Brian A. Fallon
Publication year - 2018
Publication title -
archives of clinical neuropsychology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 98
eISSN - 1873-5843
pISSN - 0887-6177
DOI - 10.1093/arclin/acy083
Subject(s) - neurocognitive , wechsler adult intelligence scale , psychomotor learning , verbal fluency test , psychology , major depressive disorder , memory span , audiology , psychiatry , clinical psychology , working memory , neuropsychology , medicine , cognition
Neurocognitive dysfunction in patients with residual or emergent symptoms after treatment for Lyme Disease is often attributed to comorbid depression. In this study, patients with Post-Treatment Lyme Disease Syndrome (PTLDS) were compared to patients with Major Depressive Disorder (MDD), as well as healthy comparison subjects (HC), on neurocognitive measures administered through the same laboratory, to determine if patterns of performance were similar.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom